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Abstract
Background: Although End Stage Renal Disease (ESRD) is a disease of increasing epidemiological relevance very
little is known about the cost of providing the respective dialysis services in Tanzania. This paper estimates the costs
of dialysis for ESRD patients at Muhimbili National Hospital (MNH) in Tanzania in the year 2014.
Methods: Cost calculations are based on the provider perspective and include only the direct cost of dialysis
treatment. Cost of drugs and consumables were obtained from the price list issued by the Medical Stores
Department (MSD) in Tanzania. Additional data were collected through face-to-face interview with experts at
the dialysis unit.
Results: MNH performs on average 442 hemodialysis per month (34 patients, with three sessions per week)
with a personnel placement of 20 nurses, four nephrologists, eight registrars, one nutritionist, two biomedical
engineers, four health attendants and nine dialysis machines. The respective average unit cost per hemodialysis is 176
US$. Consequently, an average patient requiring three dialyses per week (i.e. 156 dialyses per year) will cause annual
costs of 27,440 US$.
Conclusion: The cost of dialysis is enormous for a least developed country like Tanzania where resources and
technology are rather limited. Thus, from the economic point of view, it seems rational to allocate health care
budgets towards diseases that are curable, have a higher cost-effectiveness and cater for the majority of the
population. However, before a final decision on allocation of budgets towards dialysis is made all effort must
be invested to improve technical efficiency by cutting the enormous unit cost.
Keywords: Cost analysis; Hemodialysis; End-stage renal disease; Tanzania
Background
The incidence and prevalence of chronic kidney disease
(CKD) has significantly increased in recent years in both
developed and developing countries. This disease is con-
suming a huge proportion of health care finances in
developed countries, while contributing significantly to
morbidity, mortality and decreased expectancy of life in
the developing world [1, 2]. CKD is increasingly recog-
nized as a global public health problem and as a key de-
terminant of poor health outcomes [3]. However, CKD
prevention programs are rare in the developing world.
Contrary to some other chronic diseases such as cardio-
vascular diseases, diabetes, chronic respiratory disorders,
and cancer, CKD has not received the same degree of
attention [1].
End stage renal disease is an irreversible loss of glom-
erular filtration rate resulting from a chronic worsening
of renal function from chronic renal diseases to end-
stage renal failure. Incidence and prevalence of End
Stage Renal Disease (ESRD) requiring renal replacement
therapy (RRT) are increasing worldwide. It is estimated
that by the year 2030, more than 70 % of the patients
with ESRD will be residents of developing countries,
whose collective economies will account for less than 15 %
of the total world economy [1]. The high burden of ESRD
and associated costs, related adverse outcomes, and de-
creased productivity make it a significant public-health
problem worldwide [4].
In absence of renal transplantation (as it is the case in
many least developed countries) patients with ESRD
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depend on RRT by renal dialysis treatment for the rest of
their lives. The availability and quality of a dialysis pro-
gram largely depend on the prevailing economic condi-
tions, the political social structure, overall health care
facilities and the health care financing strategies. For the
ESRD patient in economically advanced countries, the
focus now is on improving quality of life and increasing
long-term survival. In marked contrast, developing coun-
tries are grappling with the short-term patient survival
and the enormous cost of therapy that limit continuation
of treatment in the majority of patient with ESRD [5].
The prevalence of ESRD in Sub Saharan Africa is re-
ported to be less than 100 per million [1]. However, the
credibility of statistics from many developing countries is
questionable, and the majority of experts suggest that 150
per million populations is a more realistic estimate of the
incidence of ESRD [6]. Irrespective of the tremendous
epidemiological relevance very little is known about the
cost of dialysis for hemodialysis (HD) in Sub Saharan
Africa and estimates have a wide range. In a recent review
(Mushi L, Marschall P, Flessa S, The cost of dialyis in low-
and middle-income come countries. Submitted.) found only
ten studies on the cost of hemodialysis in Sub-Saharan
Africa. They were from six countries and had extremely
diverse figures Table 1 shows the results.
For instance, the annual cost per HD patient are calcu-
lated as US$ 7000 in South Africa [7] and range between
US$ 25,000-55,000 in Nigeria [7]. Peritoneal dialysis
(PD) costs range between US$ 7000 in Egypt [8] and
between US$ 20,000-49,000 in Nigeria [7].
Etiology of ESRD in the sub region in Sub-Saharan
Africa differs from that seen in the developed world. As
opposed to the situation in Europe and the United
States, where diabetic nephropathy constitutes close to
50 % of patients on ESRD programs, the predominant
causes of ESRD in Africa are essential hypertension and
chronic glomerulonephritis [9]. Literature reports the
management of ESRD in low and middle-income countries
to be too expensive, and health care resources and budgets
are unable to meet the burden of treatment [10]. However,
lack of studies in least developed countries makes it diffi-
cult to understand the cost of dialysis in these countries so
that any allocation of health care resources cannot be
evidence-based.
To our knowledge, dialysis services were never costed
in Tanzania. This paper intends to bridge this gap by
reporting the cost of dialysis in Tanzania derived from
Muhimbili National Hospital (MNH), the highest public
referral hospital. With this data we want to support
planners and policy makers to make an evidenced based
decision concerning the allocation of scarce resources
and the provision of dialysis treatment in Tanzania. Con-
sequently, this paper provides the first estimate of unit
and annual cost of dialysis in Tanzania.
Methods
Research object
Tanzania is a least developed country [11] with a gross
national product per capita (p.c.) of 695 US$ (2012) and
health expenditure of 41 US$ p.c. (2012) [12]. For the
fiscal year 2012–2013 it allocated 10 % of its national
budget on health care services, which is below the stand-
ard of the Abuja declaration of 15 % [13]. 40 % of health
care expenditure is public with a mix of resources from
National government, Regions, Districts, and Develop-
ment Partners. A smaller group of patients are covered by
the National Health Insurance Fund (NHIF) or private
health insurances [14] but the majority of patients have to
bear a heavy load of out-of-pocket (OOP) expenditure [15].
The prevalence and incidence of CKD in Tanzania are
not known as there are no national registries for this dis-
ease. However, an alarming high prevalence of CKD
(87.3 %) among Tanzanian adult attending diabetes
mellitus clinic of Bugando medical centre in Mwanza
Tanzania has been identified [16]. Renal transplantation
is not performed in Tanzania and only few patients can
afford going abroad for an operation. Thus, hemodialysis
is the main form of Renal Replacement Therapy (RRT)
available in Tanzania. Currently, it is offered at three
public and nine private hospitals. 75 % of these service
providers and a considerable – but unknown – share of
dialysis machines are concentrated in Dar es Salaam, the
former capital of the country. Thus, the majority of
Tanzanians have no access to dialysis services due to the
high concentration in one city.
Furthermore, the majority of patients in Dar es Salaam
face severe financial barriers to access dialysis services.
As only a minority of the population is covered by NHIF
or private insurances, the majority of ESRD patients in
Tanzania would have to pay OOP for dialysis services. In
a least developed country like Tanzania where 28.2 % of
Table 1 Cost of Dialysis in Sub-Saharan Africa
Country Author(s) and year Annually cost per
patient [Int$ 2012]
Sudan Abu-Aisha and Elamin 2010 [8] 11,060
Sudan Elsharif, Elsharif et al. 2010 [9] 15,280
Senegal Abu-Aisha and Elamin 2010 [8] 28,430
Kenya Abu-Aisha and Elamin 2010 [8] 16,850
Namibia Abu-Aisha and Elamin 2010 [8] 25,800
Nigeria Okafor and Kankam 2012 [10] 42,800
Nigeria El Matri, Elhassan et al. 2008 [11] 19,700
Nigeria Abu-Aisha and Elamin 2010 [8] 36,320
South Africa Abu-Aisha and Elamin 2010 [8] 7370
South Africa El Matri, Elhassan et al. 2008 [11] 24,880
Source: Mushi L, Marschall P, Flessa S, The cost of dialyis in low- and
middle-income come countries. Submitted.
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the population is below the official poverty line [12] and
the vast majority of patients is vulnerable to poverty as
soon as they fall chronically ill dialysis patients are
always at risk of losing their lives because they cannot
afford dialysis on the free market.
The study was conducted from January to March 2014
at the hemodialysis unit of the MNH in Dar es Salaam.
With a population of 4.36 million this city accounts for
some 10 % of the total Tanzania Mainland population
[17]. MNH is a national referral and university teaching
hospital with 1500 beds and some 1000 to 1200 outpa-
tients per week. The dialysis unit at MNH is owned and
run by the government. It performs HD sessions with 10
dialysis beds in 3 shifts per day and 6 days a week. Thus,
the dialysis unit has a theoretical average capacity of 780
dialyses per month. The standard treatment requires 4 h
per dialysis and should be performed thrice per week
and patient. The unit provides dialysis services for NHIF
members and for acute patients who are exempted.
Data sample and cost categories
We took a provider perspective and calculated the cost of
dialysis based on provider expenditures. During the study
period there were 34 hemodialysis patients who under-
went outpatient dialysis treatment. All of these patients
with 442 dialyses per month were included in the analysis.
The objective of this study is not only to determine
the actual average cost per dialysis but also to produce a
cost function that allows the analysis of the impact of
changing parameters. For that purpose we could not
simply divide the total cost during the study period by
the number of dialysis but had to develop a cost func-
tion that distinguishes between variable, fixed and step-
fixed. For the costing of services we follow a standard
methodology which has been frequently applied in the
calculation of unit costs of medical procedures (e.g. [18])
and which has also been applied to the costing of dialysis
services in developed [19] and developing countries [20].
As variable cost we defined all materials and medica-
tions that can be classified directly to one hemodialysis.
These costs increase proportionally with the number of
dialysis [21]. The main variable costs are the dialyzer,
bicarbonate concentrate, blood line, normal saline, syrin-
ges, gauze sterile, needles, adhesive wound plaster, spirit,
iodine, sterile gloves, disposable mask, apron, bed sheets
and the anticoagulation heparin. Although Erythropoietin
is sometimes given during the procedure, it was excluded
from the costing as it is a consequence of the disease and
not directly caused by the dialysis.
The cost for each medication, material and the water
was determined to the best possible degree of precision.
The cost of dialysis water was obtained by calculating
water consumption of a single dialysis procedure multi-
plied by price per liter according to Dar es Salaam
Water and Sewerage Corporation rates, including sewer-
age charges and value added tax. Prices for the materials
and medication were collected from the price list issued
by the MSD in Tanzania.
Other costs that clearly increase with the number of dia-
lysis are costs for electricity, waste management, labora-
tory and sterilization. The cost of electricity per month
was calculated with the help of the electrical engineer of
the hospital. The total energy consumption per month
was calculated taking into account all electrical appliances
at the unit, watts consumed by each appliance, duration of
usage of appliances per day and number of days the unit
operates per month. The monthly electricity consumption
thus calculated was then used to calculate the monthly
electricity cost according to standard Tanzania Electric
Supply Company (TANESCO) rates. Sterilization cost was
calculated with the help of the head of the respective
department, identifying and adding together the number
of sterilized packs multiplied by the unit price to obtain
total sterilization cost per month. In addition, waste man-
agement costs were also calculated and obtained by count-
ing the total number of waste disposal buckets and the
total number of plastic bags used per day multiplied by
the unit price to obtain the total waste cost spent per
month. Laboratory cost was calculated by adding the costs
for all tests carried out during a month. Referring to the
average of 442 dialyses per month the variable cost per
dialysis was defined for the four categories, so that it is
possible to add them directly to a single dialysis.
The costs for building rent, water quality management,
service for water treatment plant and administration are
indirect, as they cannot be allocated directly to one ser-
vice unit. Thus, they do not vary with the number of dia-
lysis and are fixed costs. Building rent of the dialysis unit
was calculated with the help of the estate manager. We
measured the dialysis unit surface per square meter. The
total square meter was then multiplied by the unit price
per square meter according to Tanzania Revenue Au-
thority property tax rates to obtain the monthly rent
cost of the renal unit.
Step-fixed costs are defined as costs that are fixed within
a range; otherwise – if the volume exceeds the range – the
costs increase stepwise [22]. The cost category includes
costs for personnel, dialysis machines depreciation as well
as maintenance and repair of the machines. The personnel
of the MNH consist of medical staff (physicians, nurses,
and nutritionist) and non-medical staff (biomedical engi-
neers and health attendants). The personnel costs were
based on gross salaries and obtained from the chief
accountant of the hospital. To calculate costs per dialysis
depending on the number of dialysis per month it was
necessary to determine capacities for each staff category
and for the dialysis machines. Based on the average num-
ber of dialysis per month, the staff level, the regular
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working hours, the percentage of working time on the dia-
lysis unit, the need of machine maintenance and repair
and on the hypothesis that the staff is working on their
maximum capacity level the following monthly capacities
were obtained (Table 2). In case of an employment full-
time equivalent less than 1.00 the monthly cost for the
staff category were multiplied with the appropriate full-
time equivalent to include only dialysis related costs.
Depreciation per machine was calculated with a life time
of eight years.
To calculate the average actual full cost per dialysis de-
pending on the monthly number of dialyses the follow-





di  1þ trunc xtki
  
þ xt  v
xt
with
Ct average cost per dialysis in US$
Cf fixed costs per month in US$
di monthly costs of unit i in US$
xt number of dialysis done in period t
ki monthly capacity of unit i in US$
v variable costs of one dialysis in US$
K set of step-fixed cost units
p Fee per dialysis in US$
All monetary estimates were provided in Tanzania
Shilling (TZS) and converted to US dollar with official
2013 exchange rate published by The World Bank of
1600.44 (1 US$ = 1600.44 TZS) [23]. The cost of mate-
rials and medications were derived from the unit prices.
The data were obtained through personal measurements
as well through face-to-face interviews with experts at
the dialysis unit, with key stakeholders of NHIF head-
quarters and officials of the Ministry of Health and
Social Welfare (MoHSW) in Tanzania.
In section 3 we will also present a break-even analysis.
This standard methodology of business administration
[24] calculates the output quantity that is necessary to
recover the full costs. As a production process usually
entails fixed costs a low output level will result in a def-
icit. If the variable cost is lower than the respective rev-
enue per production unit the deficit will decrease with
growing production. The break-even point is exactly the
output level where production leaves the deficit and
starts generating a profit. A rational provider must, thus,
safeguard that he can produce and sell at least this num-
ber of output units.
This analysis follows the standard methodology of
break-even-analysis. However, as the cost function in-
cludes step-fixed costs the surplus/deficit curve is not
straight but a zig-zag curve, i.e., the break-even point is
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¼ 0
It has to be stated that the objective of this analysis was
the calculation of the actual full costs. Thus, we recorded
the reality of dialysis services in this particular hospital
and calculated the costs of real-life. Consequently, stand-
ard costs based on international standards of dialysis
services might be higher (e.g. if the standards require
more resources than applied in Tanzania) or lower (e.g. if




Table 3 describes patient’s characteristics of 34 patients in-
cluded in our study. Of the study patients, 68 % were
male. The majority (74 %) was in the age-set of 15–49
years, about a quarter (23 %) was in the age-set 50–69
years and only a few patients (3 %) were in the oldest age
set (70–89). Causes of ESRD were mainly due to chronic
glomerulonephritis, which accounted for 64 % of the study
population. Diabetes nephropathy accounted for (13 %),
hypertension for 10 %, polycystic kidney disease for 10 %,
and atypical hemolytic uremic syndrome rinse for 3 %. For
Acute Kidney Injury (AKI) causes were rapidly progressive
glomerulonephritis (67 %) and placenta abruption (33 %).
In addition, patients had different types of vascular access
including catheter, arteriovenous (AV) fistula and AV graft.
Among them, 62 % had a catheter as an access point,
35 % had AV fistula and the rest 3 % had AV graft.
Cost analysis
Tables 4, 5 and 6 show the cost categories for fixed, vari-
able and jump-fixed costs. The fixed cost of the dialysis
department is 2990 US$ per month and the variable cost











Biomedical Engineer 221 1.00
Health attendants 111 1.00
Source: Muhimbili National Hospital (MNH)
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per dialysis is 80 US$. The strongest cost driver is the
dialyzer high flux with 25 US$ and the sterilization with
13 US$. Table 2 exhibits the capacities of the resources
with jumped-fixed costs, the respective unit costs are
expressed in Table 6. It has to be noted that the costs of
personnel do not reflect their net salary but the total
cost for the employer, including all allowances, pension
fund, insurance, garments etc. In particular the cost per
nurse seems to be high but these are specialized nurses
with academic degrees who are scarce in Tanzania.
Based on the number of 34 patients with 442 dialysis
per month the average cost per dialysis is 176 US$. This
includes the apportioned costs for 20 nurses, four
nephrologists (full-time equivalent 2.80), eight registrars
(full-time equivalent 2.50), one nutritionist (full-time
equivalent 0.50), two biomedical engineers, four health
attendants and nine dialysis machines.
As discussed before the unit costs depend on the
number of dialyses performed. Figure 1 shows the re-
spective results.
Figure 1 clearly indicates that the average costs per
dialysis strongly decrease with an increasing number of












Causes of ESRD 31
Chronic Glomerulonephritis 20 64
Diabetes nephropathy 4 13
Hypertension 3 10
Polycystic 3 10
Atypical hemolytic uremic syndrome
rinse
1 3
Causes of AKI 3
Rapidly progressive glomerulonephritis 2 67
Placenta abruption 1 33
Type of vascular access
Catheter (jugular, subclavian, femoral) 21 62
Arteriovenous fistula 12 35
Arteriovenous graft 1 3
Source: Muhimbili National Hospital (MNH)
Table 4 Fixed Cost
Cost category cost per month [US$]
Rent/month 2455.57
water Quality mgt 418.63
servicing of water treatment plant 53.01
Administration 62.98
sum of fixed cost per month 2990.20
source: Muhimbili National Hospital (MNH)
Table 5 Variable Cost
Cost category cost per dialysis [US$]
Dialyzer high flux 24.51
Bibag 1 4.37
Blood line 6.25
Nornal saline 500mls (2x) 0.31
Syringes 20 cm3 0.09
Syringes 10 cm3 (4x) 0.27
Syringes 5 cm3 (4x) 0.15
Iv giving set 0.94
Heparin 5000 I.u 4.37
Gauze sterile 1roll 40000 3.12
Adhesive wound plaster 1pair 0.69
spirit 20mls 8.12
Iodine providine 20mls 1.56
Sterile gloves (pair) (4x) 0.40
clean gloves (pair) (4x) 0.40
Disposable mask (2x) 0.62
safety boxes 0.62
Plastic Apron disposable 1.25




laundry (4sheets per dialysis) 5.00
sterilization 13.12
sum of variable (per dialysis) 80.21
Source: Muhimbili National Hospital (MNH)
Table 6 Jump-Fixed Cost
Cost category unit cost per month [US$]








source: Muhimbili National Hospital (MNH)
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dialysis per month. The notable leaps show the influence
of the step-fixed cost categories which cause higher costs
if the maximum capacity of one step-fixed category is
exceeded. Related to the fact that dialysis treatments are
performed three times a week and 52 weeks per year,
the average number of dialysis per patients and month is
13. It has to be considered that in case of a lower num-
ber of patients, the analysis also calculates with a lower
need of personnel based on the mentioned capacities
and working times on the dialysis unit. For example this
would mean that the average cost per dialysis for a unit
with 15 patients would be 192 US$, with 30 patients 178
US$, with 45 patient 177 US$ and with 60 patients 174
US$. Contrary to the cost range of these four examples a
dialysis unit with only 3 patients would cause average
costs of 331 US$ per dialysis. The reason for that is the
increasing amount of fixed and step-fixed costs per cost-
ing unit in case of a lower number of dialysis per month.
Figure 2 shows the total monthly unit costs as a sum
of the total fixed costs (fixed and step-fixed) and the
variable costs depending on the number of dialysis per
month. Based on the analysis with nine machines at a
number of 34 patients with an average of 442 dialysis
per month the total monthly costs are 77,750 US$.
Break-even analysis
For patients with a public insurance the National Health
Insurance Fund of Tanzania pays 187 US$ for a single
HD. Relating to the results of Fig. 1 it is possible to
calculate the average profit or loss per dialysis depending
on the number of sessions per month. The results are
shown in Fig. 3.
Figure 3 shows that a cost recovery is not given for every
possible number of dialysis per month. Because of the
influence of the step fixed costs, cost coverage is given in
the areas between 203 to 207, 216 to 221 and 272 to 276
Fig. 1 Average costs per dialysis
Fig. 2 Monthly cost of the dialysis department
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and above 288. To focus on these areas in case of planning
the number of dialysis for the long run is not be advisable
for a dialysis unit because of uncertainties in the future.
The realistic point of break-even is at 288 dialyses. Beyond
this number the department is able to cover the costs and
to generate a surplus. Referring to the 13 dialyses per
patient and month the number of 288 dialyses would be
equivalent to 22.15 patients. Therefore, the minimum
number of patients of an outpatient dialysis unit with only
NHIF-insured patients should be at least 23. In case of the
MNH the average surplus per dialysis is at 12 US$.
Sensitivity analyses
The results presented above are subject to uncertainty of
parameters. Therefore, we calculated the average cost per
hemodialysis subject to different inputs (e.g. nutritionist,
engineer, health attendants) and costs (e.g. rent, salaries,
materials) of resources as well as different capacities of
dialysis machines and personnel. Table 7 presents the
results. The column “scenario” shows the parameters that
are changed and the column “value of parameters” the
new value. All other parameters are the standards given
above (ceteris paribus). Unit costs are calculated for a
utilization of 34 patients with 442 dialyses per month.
It is obvious that lower unit cost per dialysis is possible
if some cost categories are not included (e.g. rent), prices
and salaries are lower (e.g. dialyzer high flux) and cap-
acities are increased. A combined realistic scenario is pre-
sented in the last row. If rent is not included (because
Muhimbili facilities are financed by the Government of
Tanzania), if a nurse can handle up to 40 dialyses per
month, if the dialyzer high flux costs on 15 US$ per
dialysis and if the cost of sterilization is reduced to 5 US$
per dialysis the unit cost can decline to 131 US$.
Fig. 3 Surplus per dialysis





Basic see Tables 2, 4, 5, 6 176
nutritionist 0 [number] 174
biomedical engineer 0 [number] 170
health attendant 0 [number] 173
nurse capacity 40 dialysis per month 155
rent 0 [US$ per month] 170
cost of dialyzer high flux 15 [S$ per dialysis] 166
cost of sterilization 5 [US$ per dialysis] 168
dialysis machines
(depreciation and repair)










+25 % / +20 % 166
+25 % / +40 % 156
+50 % / +60 % 149
+50 % / +80 % 146
+50 % / +100 % 133
rent 0 Euro 131
nurse capacity 40 dialyses per month
cost of dialyzer high flux per dialysis 15 US$
cost of sterilization 5 US$ per dialysis
Source: own
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Discussion
CKD affects mainly young adults in their economically
productive years aged 15–49. These findings are in con-
sistence with other studies that reported an age of 20–50
years in Sub-Saharan Africa [25]. Contrary to this finding,
in the developed world, CKD is present in the middle-
aged and elderly patients and it’s predominantly due to
diabetes nephropathy and hypertension [2].
The analysis has shown the average costs of a single
dialysis and the total cost per month depending on the
number of treatments. As Fig. 3 indicates, the hospital
should perform at least 288 dialyses (equivalent to 22.15
patients) in order to break-even. However, if a dialysis
patient needs erythropoietin – which is possibly not cov-
ered completely by revenues for the treatment of renal
anemia – the dialysis surplus could be reduced by a kind
of internal subsidization. This means that the surplus of
dialysis treatments could be used for the compensation
of possible losses in case of renal anemia treatments. For
example, in case of the mentioned 34 patients at MNH
90 % needed erythropoietin with actual costs of 61.80
US$ per dialysis. This results in an average of 56 US$
per dialysis.
The results show that cost recovery in case of intermit-
tent outpatient dialysis treatments is possible depending
on the number of patients. According to latest informa-
tion the number of patients under hemodialysis treatment
has increased to 60 so that the average cost has declined
to 174 US$. This is a tremendous increase and the
respective figures indicate that the department is likely to
generate a profit. However, it is not likely that the number
of patients will increase even more as the department has
come to its capacity limits. Firstly, nephrologists and
specialized nurses are a rare category of staff in Tanzania.
The cost curve assumes that more staff will be available
but this is not guaranteed. Secondly, space in Muhimbili is
scarce and a stronger increase of capacity would require
more space which is most likely not available. Thirdly,
there is doubt that the financing institutions are able and
willing to sponsor many more patients. Thus, a strong
increase in number is unlikely to happen.
At the same time, the results are based on the MNH at
Dar es Salaam, a hospital of maximum treatment in the
economic center and biggest agglomeration of Tanzania.
It can be assumed that the results are partly transferable
to dialysis units of larger hospitals in urban areas in this
East African country. Transferability to providers in rural
areas has to be doubted because of influencing factors like
infrastructural conditions and a low population density.
This means that dialysis centers in rural areas probably
would have to calculate with higher average costs per
treatment because of higher materials costs and with
lower possible numbers of patients because of a lower
population in the maximum catchment area. Therefore,
an area-covering supply with renal replacement services
in rural areas of developing countries appears to be very
difficult to implement. Even though the majority of
patients requiring dialysis are likely to live in urban places,
still there are patients suffering from chronic kidney
diseases in rural places – and it is very unlikely that they
will find dialysis services there.
In case of the dialysis unit at the MNH with 34 patients
the average costs per dialysis is 176 US$. Assuming that a
dialysis patient is treated three times a week, 52 week a
year, the yearly number of dialysis is 156. Referring to this,
the annual cost per patient is 27,440 US$ (see Fig. 4).
Conclusion
In summary we can state that this cost analysis can pro-
vide the foundation of evidence based policy-making in
the health care sector, efficient allocation of funds to-
wards this specific service and proper calculation of fees.
Fig. 4 Annual cost per patient
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At the same time the cost of dialysis per patient per year
is tremendous for a least developed country like Tanzania
where resources are limited and materials have to be
imported at high cost. Other diseases prevailing have a
much higher burden of disease while being preventable
and curable at much lower cost. Thus, ESRD and dialysis
are a good example for the terrible dilemma which public
health planners and policy-makers face in least developed
countries: they have to allocate scarce resource to specific
interventions. Neglecting dialysis patients will cause their
death – but allocating high resource to them will mean
that these resources will be missing for the fight against
other diseases. The question “who shall live?” [26] is the
terrible reality of policy-makers in Tanzania.
However, before an allocation decision can be made
every effort has to be invested to reduce the high actual
cost by improving the technical efficiency of the dialysis
departments. In order to assess the relative technical ef-
ficiency it is worthwhile to compare our results with cost
of other low income countries. (Mushi L, Marschall P,
Flessa S, The cost of dialyis in low- and middle-income
come countries. Submitted.) calculated the annual cost
per patient for hemodialysis and compared them with
the gross national product. As Fig. 5 shows, the costs
calculated in our study are higher than the expected
value, in particular the cost of personnel were quite high
(48 % of total cost). Contrary, Hooi et al., [27] found for
Malaysia that the personnel cost consumes 19 % of total
cost while consumables and drugs consume 26 % of all
costs. In Sri Lanka, Ranasinghe et al. [20] found that drug
and consumables costs accounted for 70–85 % of the total
cost, followed by the wage of nursing staff 8 %–20 %.
In particular striking is the fact that the cost of dia-
lyzer high flux in Tanzania is higher than in the devel-
oped world. It is beyond this study to address the issue
of tariffs and taxes on medical equipment and materials,
but before dialysis services are excluded from the basic
health care package the issue of extraordinary materials
cost has to be discussed within the country.
At the same time, the cost allocated to the dialysis unit
for sterilization of medical equipment seems to be high.
This figure was given by the hospital administration but
it has to be questioned whether sterilization services
could be obtained at a lower rate from outside the hos-
pital. Furthermore, the highest fixed cost is the rent of
the building. As this analysis calculates actual full costs
it is appropriate to include it in the computation. How-
ever, it is unfair to compare the full cost of dialysis with
the marginal cost of other services – and many cost ana-
lyses do not include rent or maintenance.
Finally, we have to question whether the staffing pat-
tern was appropriate during our study period. Based on
international standards this department was strongly
over-staffed. It is beyond the scope of this paper to as-
sess why such an input of nurses was needed per dialysis
in Tanzania, but technical efficiency could be improved
by reducing the nursing time per dialysis. In fact, the
number of patients has increased in the meantime while
staffing remained almost unchanged.
If we assume the assumptions of the combined sce-
nario of Table 7 (no rent, nurse capacity 40 dialyses per
month, cost of the dialyzer high flux per dialysis 15 US$,
cost of sterilization 5 US$ per dialysis) the average cost
per dialysis decline to 131 US$ and the total cost per
patient per year to 20,500 US$. Thus, increased technical
efficiency could buy one year of life with some 20,500
US$ - an amount that is still far beyond the traditional
threshold of gross national product per capita.
One might argue that hemodialysis is a cost-intensive
form of dialysis and peritoneal dialysis (PD) would be
Fig. 5 Annual cost of HD per patient in different countries. Source: own and [25]
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more adequate for a country like Tanzania. Currently,
PD is not available in this East African country, but one
might advise the Ministry of Health to foster the intro-
duction of this technology. However, the literature on
the cost of PD in less and least developed countries is
even more scarce than for HD and it does not strongly
support the assumption that PD is always less expensive
than HD. It holds true for developed countries which
manufacture PD solution themselves. In some countries
the costs seem to be equal, e.g. in China [28] and
Namibia [7]. In other of countries the cost of PD are re-
ported higher than the cost of HD, for instance for Sri
Lanka HD [28], Bangladesh [28] and Sudan [7]. Conse-
quently, Tanzania which has to import PD solutions
completely would have to make a thorough analysis be-
fore decisions could be done.
Consequently, the findings of this study indicate that
hemodialysis services in Tanzania are a very resource
intensive technology in comparison to the health care
budget of the nation. It seems more rational to allocate
health care budgets towards diseases that can be pre-
vented, cured or treated at lower costs. But the people of
Tanzania should decide themselves in a transparent pol-
itical process on their health care package. Political deci-
sions are influenced by many factors, not only economic
evidence [29]. However, the knowledge of provider cost
is one cornerstone of transparency in this endeavour but
more research on household cost, quality of life of dialy-
sis patients, quality of services, effectiveness, efficiency
and alternatives to dialysis is needed to base allocation
decisions on evidence.
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